Development and validation of SIMS: An instrument for measuring quality of life of adults with sickle cell disease

American Journal of Hematology

Volumn 83, Issue 7, 2008, Pages 558-562

  Adams Graves, Patricia ^a   Lamar, Kimberly ^a   Johnson, Cage ^b   Corley, Pat ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; FACTORIAL ANALYSIS; HUMAN; INFORMATION PROCESSING; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SELF EVALUATION; SICKLE CELL ANEMIA; SICKLE CELL IMPACT MEASUREMENT SCALE; SOCIAL INTERACTION; WELLBEING;

ADULT; ANEMIA, SICKLE CELL; ARTHRITIS, RHEUMATOID; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 45749140941     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21146     Document Type: Article

References (37)

1. Embury S, Steinburg M, Mohandas N, Hebbel R. Pathophysiology overview. In: Embury S, editor. Sickle Cell Disease Basic Principles and Clinical Practice. New York: Raven Press, 1994. pp 233-234.
2. BS, Ballas SK. The acute painful episode. In: Embury S, editor. Sickle Cell Disease Basic Principles and Clinical Practice. New York: Raven Press; 1994. pp 531-544.
3. Beutler E. The sickle cell diseases and related disorcers. In: Beutler E, Lichtman M, Coller B, et al., editors. Willliams Hematology,6th ed. New York: McGraw-Hill; 2001. pp 581-606.
4. McClish DK, Penberthy LT, Bovberg VE, et al. Health related quality of life in sickle cell patients. The PiSCES project. Health Qual Life Outcomes 2005; 29:3-50.
5. Guyatt GH, Peeny DH, Patrick DL. Measuring heahh-related quality of life. Ann Intern Med 1993;118:662-629.
6. Carr AJ, Thompson PW, Kirwan JR. Quality of life measures. Br J Rheumatol 1996;35:275-81.
7. Miettinen OS. Quality of life from the epidemiologic perspective. J Chronic Dis 1987;40:641-643.
8. Gladis MM, Gosch EA, Dishuk NM, Crits-Christoph P. Quality of life: Expanding the scope of clinical significance. J Consult Clin Psychol 1999;67:320-331.
9. Lubetkin EL, Gold MR. Comprehensibility of measures of health-related quality of life in minority and low-income patients. J Natl Medical Assoc 2002; 94:327-335.
10. Brook RH, Ware JE Jr, Davies-Avery A, et al. Conceptualization and Measurement of Health for Adults in the Health Insurance Study, Vol. 8: Overview. Santa Monica, CA: Rand Corporation; 1979.
11. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Validity of the child health questionnaire for use in children with sickle cell disease. J Pediat Hematol/ Oncol 2004;26:574-578.
12. McHorney C, Ware JE Jr, Raczek A. The MOS 36-item short-form health survey (SF-36). II. Psychometrick and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;32:247-263.
13. Meenan RF. The AIMS approach to health status measurement: Conceptual background and measurement properties. J Rheumatol 1982;9:785-788.
14. Meenan RF, Gertman PM, Mason JH, Dunaif R. The arthritis impact measurement scales: Further investigations of a health status measure. Arthritis Rheum 1982;25:1048-1053.
15. Meenan RF, Anderson JJ, Kazis LE, et al. Outcome assessment in clinical trials: Evidence for the sensitivity of a health status measure. Arthritis Rheum 1984;27:1344-1352.
16. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 1994;12:608-616.
17. Wachtel T, Piette J, Mor V, et al. Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrument. Ann Intern Med 1992;116:129-137.
18. Baker GA. Health-related quality-of-life issues: Optimizing patient outcomes. Neurology 1995;45 (Suppl 2):S29-S34.
19. Kosmidis P. Quality of life as a new end point. Chest 1996;109(5 Suppl): 110S-112S.
20. Hoffman LG, Rouse MW, Brin BN. Quality of life: A review. J Am Optom Assoc 1995;66:281-289.
21. Smith KW, Avis NF, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Qual Life Res 1999; 8:447-459.
22. Strickland OL, Jackson G, Gilead M, et al. Use of focus groups for pain and quality of life assessment in adults with sickle cell disease. J Natl Black Nurses Assoc 2001;12:36-43.
23. Woods K, Kutlar A, Johnson JA, et al. Sickle cell telemedicine clinics and standard encounters: A comparison of patient satisfaction. Telemed J 1999;5: 349-356.
24. Hasan SP, Hashmi S, Alhassen M, et al. Depression in sickle cell disease. J Natl Med Assoc 2003;95:533-537.
25. Thomas VJ, Taylor LM. The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. Br J Health Psychol 2002;7 (Part 3):345-363.
26. Anie KA, Steptoe A, Bevan DH. Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK. Br J Health Psychol 2002;7 (Part 3): 331-344.
27. Harrison MO, Edwards CL, Koenig HG, et al. Religiosity/spirituality and pain in patients with sickle cell disease. J Nerv Ment Dis 2005;193:250-257.
28. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Health-related quality of life in children with sickle cell disease: Child and parent perception. Br J Hematol 2005;130:437-444.
29. Anderson LP, Rehm LP. The relationship between strategies of coping and perception of pain in three chronic pain groups. J Clin Psychol 1984;40:1170-1177.
30. Gil KM, Abrams MR, Phillips G, Keefe FJ. Sickle cell disease pain: Relation of coping strategies to adjustment. J Consult Clin Psychol 1989;57:725-731.
31. Damlouji NF, Kevess-Cohen R, Charache S, et al. Social disability and psychiatric morbidity in sickle cell anemia and diabetes patients. Psychosomatics 1982;23:925-931.
32. Barrett DH, Wisotzek IE, Abel GG, et al. Assessment of psychosocial functioning of patients with sickle cell disease. South Med J 1988;81:745-750.
33. Strawbridge WJ. Quality of life: What is it and can it be measured? Growth Horm IGF Res 1998;8 (Suppl A):59-62.
34. Derogatis LR, Loper MC. PAIS and PAIS-SR: Administration, Scoring and Procedures Manual-I. Baltimore: Clinical Psychometric Research, 1983.
35. Derogatis LR. Scoring and Procedures Manual for PAIS. Baltimore: Clinical Psychometric Research, 1976.
36. Jaeschke R, Guyatt GH. How to develop and validate a new quality of life instrument. In Spilker B, editor. Quality of Life Assessements in Clinical Trials. New York: Raven Press, 1990.
37. Cooksey RW, Hattie J. Procedures for assessing the validities of tests using the known-groups method. Appl Psychol Meas 1984;8:295-305.